4
Jan
2023
Yesterday, FDA announced modifications to the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone (Mifeprex–Danco Labs) that enable pharmacies to become certified to dispense this FDA-approved drug to patients with a prescription, as long as they comply with the certification requirements.
Categories: Press Releases
Tags: Press Releases, press release
14
Nov
2022
WASHINGTON, D.C. – The American Pharmacists Association (APhA) hailed the Federal Trade Commission’s (FTC) statement restoring the agency’s policy of rigorously enforcing the federal ban on unfair methods of competition
WASHINGTON, D.C. – The American Pharmacists Association (APhA) today hailed the release of a peer-reviewed study that found that community-based pharmacists and their teams administered more than 270 million COVID-19 vaccinations in community pharmacies alone through September 2022.
3
Washington, DC — Today, APhA released the following statement regarding the CDC’s Updated Pain Management Guidelines.
18
Oct
The National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA) and the National Association of Chain Drug Stores (NACDS), along with American Pharmacies (APRx) and the Oklahoma Pharmacists Association (OPhA)